Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Stillbirths: contribution of preterm birth and size-for-gestational age for 119.6 million total births from nationwide records in 12 countries, 2000 to 2020

Y. B. Okwaraji, L. Suárez-Idueta, E.O. Ohuma, E. Bradley, J. Yargawa, V. Pingray, G. Cormick, A. Gordon, V. Flenady, E. Horváth-Puhó, H.T. Sørensen, L. Sakeus, L. Abuladze, M. Heidarzadeh, N. Khalili, K. A. Yunis, A. Al Bizri, SD. Karalasingam, J. Ravichandran, A. Barranco, Aimée E. van Dijk, L. Broeders, F.F. Alyafei, M. AlQubaisi, N. Razaz, J. Söderling, L. K. Smith, R. J. Matthews, R. Wood, K. Monteath, I. Pereyra, G. Pravia, S. Lisonkova, Q. Wen, View ORCID ProfileJ. E. Lawn, H. Blencowe the National Vulnerable Newborn Collaborative Group for stillbirths
doi: https://doi.org/10.1101/2023.04.14.23288565
Y. B. Okwaraji
1Maternal, Adolescent, Reproductive &Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Yemisrach.okwaraji{at}lshtm.ac.uk
L. Suárez-Idueta
2Mexican Society of Public Health, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.O. Ohuma
1Maternal, Adolescent, Reproductive &Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Bradley
1Maternal, Adolescent, Reproductive &Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Yargawa
1Maternal, Adolescent, Reproductive &Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Pingray
3Institute for Clinical Effectiveness and Health Policy, Ciudad Autónoma de Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Cormick
3Institute for Clinical Effectiveness and Health Policy, Ciudad Autónoma de Buenos Aires, Argentina
4Centro de Investigaciones en Epidemiología y Salud Pública, National Scientific and Technical Research Council (CONICET), Ciudad Autónoma de Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Gordon
5University of Sydney, Faculty of Medicine and Health, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Flenady
5University of Sydney, Faculty of Medicine and Health, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Horváth-Puhó
6Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.T. Sørensen
6Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Sakeus
7School of Governance, Law and Society, Estonian Institute for Population Studies, Tallinn University, Tallinn, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Abuladze
7School of Governance, Law and Society, Estonian Institute for Population Studies, Tallinn University, Tallinn, Estonia
8Population Research Unit, Väestöliitto, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Heidarzadeh
9Alzahra Hospital Iran, Paediatrics department, Tabriz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Khalili
10Preventive Medicine and Public Health Research Centre, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. A. Yunis
11Division of Neonatology, Department of Paediatrics and Adolescent Medicine, American University of Beirut, Beirut, Lebanon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Al Bizri
11Division of Neonatology, Department of Paediatrics and Adolescent Medicine, American University of Beirut, Beirut, Lebanon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SD. Karalasingam
12Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Cyberjaya, Cyberjaya, Malaysia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Ravichandran
13Malaysia Monash Medical School, Dept of Obstetrics & Gynaecology, Johor Bahru, Malaysia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Barranco
14Directorate of Health Information, Ministry of Health, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aimée E. van Dijk
15Perined, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Broeders
15Perined, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F.F. Alyafei
16Department of Paediatrics, Hamad General Hospital, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. AlQubaisi
17NICU, Women Wellness and Research Center, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Razaz
18Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Söderling
18Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. K. Smith
19Department of Population Health Sciences, College of Life Sciences, University of Leicester, Leicester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. J. Matthews
19Department of Population Health Sciences, College of Life Sciences, University of Leicester, Leicester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Wood
20Public Health Scotland, Edinburgh, UK and Usher Institute, University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Monteath
21Pregnancy, Birth and Child Health Team, Public Health Scotland, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Pereyra
22Faculty of Health Sciences, Catholic University of Maule, Curicó, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Pravia
23Department of Wellness and health, Catholic University of Uruguay, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Lisonkova
24Department of Obstetrics & Gynaecology, University of British Columbia, Vancouver, Canada
25School of Population and Public Health, University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Q. Wen
24Department of Obstetrics & Gynaecology, University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. E. Lawn
1Maternal, Adolescent, Reproductive &Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. E. Lawn
H. Blencowe
1Maternal, Adolescent, Reproductive &Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To examine the contribution of preterm birth and size-for-gestational age in stillbirths using six ‘newborn types’.

Design Population-based multi-country analyses.

Setting Births collected through routine data systems in 12 countries.

Sample 119,644,788 total births from 22+0 to 44+6 weeks gestation identified from 2000 to 2020.

Methods We included 605,557 stillbirths from 22+0 weeks gestation from 12 countries. We classified all births, including stillbirths, by six ‘newborn types’ based on gestational age information (preterm, PT, <37+0 weeks vs term, T, ≥37+0 weeks) and size-for-gestational age defined as small (SGA, <10th centile), appropriate (AGA, 10th-90th centiles), or large (LGA, >90th centile) for gestational age, according to the international newborn size for gestational age and sex INTERGROWTH-21st standards.

Main Outcome Measures Distribution of stillbirths, stillbirth rates and rate ratios according to six newborn types.

Results 605,557 (0.50%) of the 119,644,788 total births resulted in stillbirth after 22+0 weeks. Most stillbirths (74.3%) were preterm. Around 21.0% were SGA types (PT+SGA (16.0%), T+SGA (5.0%)) and 14.3% were LGA types (PT+LGA (10.1%), T+LGA (4.2%)). The median rate ratio (RR) for stillbirth was highest in PT+SGA babies (RR=78.8, interquartile range (IQR), 68.2, 111.5) followed by PT+AGA (RR=24.5, IQR, 19.3, 29.4), PT+LGA (RR=23.0, IQR,13.7, 29.0) and T+SGA (RR=5.5, IQR, 5.0, 6.0) compared with T+AGA. Stillbirth rate ratios were similar for T+LGA vs T+AGA (RR=0.7, IQR, 0.7, 1.1). At the population level, 21.5% of stillbirths were attributable to small-for-gestational-age.

Conclusions In these high-quality data from high/middle income countries, almost three quarters of stillbirths were born preterm and a fifth were small-for-gestational age, with the highest stillbirth rates associated with the coexistence of preterm and SGA. Further analyses are needed to better understand patterns of gestation-specific risk in these populations, and also patterns in lower-income contexts, especially those with higher rates of intrapartum stillbirth and SGA.

Funding The Children’s Investment Fund Foundation, 1803-02535

WHAT WAS KNOWN?Stillbirth (pregnancy loss after 22+0 weeks) is a devastating outcome. Global estimates indicating 1.9 million late gestation stillbirths (≥28+0 weeks) worldwide in 2021 underestimate the overall burden. Many of the pathways to stillbirth result in fetal death before term (preterm stillbirth, <37+0 weeks of gestational age). In addition, babies with fetal growth restriction (frequently assessed using the proxy small for gestational age (SGA, <10th centile)) are at higher risk of stillbirth than their appropriately grown peers. Stillbirths are therefore more likely to be low birthweight (LBW, <2,500g). Being large for gestational age (LGA, >90th centile) at term may also be associated with increased risk of stillbirth.

WHAT WAS DONE THAT IS NEW?Combining information on gestational age (preterm (PT), or term (T)) and attained size for-gestational-age (small-for-gestational-age (SGA), appropriate-for-gestational age (AGA), large-for-gestational age (LGA)) we defined six ‘newborn types’: four small (PT+SGA, PT+AGA, PT+LGA, T+SGA), one large (T+LGA), and one reference (T+AGA). We compiled livebirth and stillbirth data from 15 high- and middle-income countries as part of the Vulnerable Newborn Collaboration. A total of 119,039,231 livebirths and 605,557 stillbirths ≥22+0 weeks from 12 countries between 2000 and 2020 met the inclusion criteria. We examined the distribution of stillbirths by these ‘newborn types’, and calculated type-specific stillbirth rates and rate ratios.

WHAT WAS FOUND?Most stillbirths (74.3%) were preterm, compared to fewer than 1-in-10 (9.0%) livebirths. A fifth (21.0%) of stillbirths were SGA compared to 1-in-20 (5.4%) livebirths. Preterm SGA had 78.8 times higher stillbirth rates compared to term AGA (Rate ratio (RR)=78.8, interquartile range (IQR), 68.2,111.5). Overall, preterm types had a 25 times higher stillbirth rate than term types (RR=25.0, IQR,20.1, 29.5). At the population level, over a fifth of stillbirths (21.5%) were attributable to being SGA, indicating a substantial impact of growth restriction on stillbirth in these settings. 14.3% of stillbirths and 17.5% of livebirths were LGA. There was no evidence of increased stillbirth rates for LGA types. The distribution of these ‘newborn types’ are similar amongst stillbirths and neonatal deaths.

WHAT NEXT?Categorisation of all births, including stillbirths, into these ‘newborn types’ was analytically possible using routinely collected data in these 12 upper-middle- or high-income contexts and led to programmatic relevant findings. However, as the majority (98%) of the world’s stillbirths are in low-and middle-income countries, more data are needed to improve understanding of patterns in stillbirths in a wider range of contexts, especially in settings with higher rates of intrapartum stillbirth and those with very high SGA rates such as South Asia. Further analyses, including assessing gestational age-specific risk, could provide more information on pathways to stillbirth and enable targeted interventions to underlying causes such as infection and obstetric complications. When analysing these vulnerability pathways, omitting stillbirths neglects an important part of the burden and its effects on families and society.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The Childrens Investment Fund Foundation, prime grant 1803-02535. The funders had no role in the study design, data collection, analysis, interpretation of the data, or the decision to submit for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval London School of Hygiene & Tropical Medicine (LSHTM)LSHTM - Observational / Interventions Research Ethics Committee2285817th May 2021 EstoniaEthics Committee of National Institute for Health Development77009th August 2021 Iran Iran University of Medical Sciences, Tehran, IranIR.IUMS.REC.1400.75821st November 2021 LebanonInstitutional Review Board, American University of BeirutPED.KY.0113th July 2021 MalaysiaMedical Research & Ethics Committee, Ministry of Health MalaysiaKKM/NIHSEC/ P21-718 (4)5the May 2021 MexicoCentre of Investigation in Health Sciences, Anahuac University, Mexico20221431st March 2022 QatarMedical Research Centre, Hamad Medical Corporation, Doha-QatarMRC-01-21-27725th April 2021 Kentland and Wales1. National Information Governance Board 2. Confidentiality Advisory Group of the Health Research Authority 3. Health & Social Care Information Centre (HSCIC), Data Access Advisory Group1. ECC 5-05 (f)/2012 2. 15/CAG/0119 3. DARS-NIC-359651-H3R1P-v5.2. 10th October 2012 and 1st May2015 UK ScotlandPublic Health Scotland20210218-Vulnerable Newborn Measurement30th March 2021 Exemptions (e.g., IRB approval not required for public or aggregate data, existing ethics approval in place, etc) Argentina Denmark Netherlands Sweden Uruguay USA publicly available data from https://www.cdc.gov/nchs/data_access/Vitalstatsonline.htm

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ↵+ Joint first authors

  • ↵* Joint senior authors

Data Availability

Data sharing and transfer agreements were jointly developed and signed by all collaborating partners. The pooled summary table data generated during the current study are deposited online with data access subject to approval at https://doi.org/10.17037/DATA.00003095 except for those from countries where data sharing is not permitted.

https://doi.org/10.17037/DATA.00003095

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 17, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Stillbirths: contribution of preterm birth and size-for-gestational age for 119.6 million total births from nationwide records in 12 countries, 2000 to 2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Stillbirths: contribution of preterm birth and size-for-gestational age for 119.6 million total births from nationwide records in 12 countries, 2000 to 2020
Y. B. Okwaraji, L. Suárez-Idueta, E.O. Ohuma, E. Bradley, J. Yargawa, V. Pingray, G. Cormick, A. Gordon, V. Flenady, E. Horváth-Puhó, H.T. Sørensen, L. Sakeus, L. Abuladze, M. Heidarzadeh, N. Khalili, K. A. Yunis, A. Al Bizri, SD. Karalasingam, J. Ravichandran, A. Barranco, Aimée E. van Dijk, L. Broeders, F.F. Alyafei, M. AlQubaisi, N. Razaz, J. Söderling, L. K. Smith, R. J. Matthews, R. Wood, K. Monteath, I. Pereyra, G. Pravia, S. Lisonkova, Q. Wen, J. E. Lawn, H. Blencowe
medRxiv 2023.04.14.23288565; doi: https://doi.org/10.1101/2023.04.14.23288565
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Stillbirths: contribution of preterm birth and size-for-gestational age for 119.6 million total births from nationwide records in 12 countries, 2000 to 2020
Y. B. Okwaraji, L. Suárez-Idueta, E.O. Ohuma, E. Bradley, J. Yargawa, V. Pingray, G. Cormick, A. Gordon, V. Flenady, E. Horváth-Puhó, H.T. Sørensen, L. Sakeus, L. Abuladze, M. Heidarzadeh, N. Khalili, K. A. Yunis, A. Al Bizri, SD. Karalasingam, J. Ravichandran, A. Barranco, Aimée E. van Dijk, L. Broeders, F.F. Alyafei, M. AlQubaisi, N. Razaz, J. Söderling, L. K. Smith, R. J. Matthews, R. Wood, K. Monteath, I. Pereyra, G. Pravia, S. Lisonkova, Q. Wen, J. E. Lawn, H. Blencowe
medRxiv 2023.04.14.23288565; doi: https://doi.org/10.1101/2023.04.14.23288565

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)